New drug atogepant to prevent migraine may start working right away, reports research Dr. Kamal Kant Kohli29 Dec 2024 8:30 PM IST A drug recently approved to prevent migraine may start working right away, according to a study published in the December 23, 2024, online issue...
Medical Bulletin 26/ December/ 2024 Dr. Bhumika Maikhuri26 Dec 2024 3:00 PM ISTHere are the top medical news for the day:Researchers Unveil Efficacy and Safety of New Migraine DrugA drug recently approved to prevent migraine may...
New Migraine Drug May Start Working Right Away: Researchers Dr. Bhumika Maikhuri26 Dec 2024 8:00 AM ISTA drug recently approved to prevent migraine may start working right away, according to a study published online issue of Neurology, the medical...
AbbVie gets European Commission nod for Aquipta for prophylaxis of migraine in adults Ruchika Sharma20 Aug 2023 3:00 PM ISTNorth Chicago: AbbVie has announced that the European Commission has approved AQUIPTA (atogepant) for the prophylaxis of migraine in adults...
Atogepant effectively prevents episodic migraine: ELEVATE Study Jacinthlyn Sylvia24 April 2023 9:45 AM ISTThe ELEVATE study found that atogepant (Qulipta) outperformed placebo for preventing migraines in patients with episodic migraine who were resistant...
AbbVie seeks EMA approval for Atogepant for prophylaxis treatment of Migraine Ruchika Sharma19 July 2022 1:45 PM ISTAtogepant is an orally administered, CGRP receptor antagonist (gepant) specifically developed for the prophylaxis treatment of migraine.
AbbVie files sNDA to USFDA for Atogepant for chronic migraine treatment Ruchika Sharma22 Jun 2022 1:30 PM ISTNorth Chicago, Ill.: AbbVie has announced that the company has submitted a supplemental New Drug Application (sNDA) for atogepant (QULIPTA) to the...
Atogepant- new solution for migraines Jacinthlyn Sylvia17 Jun 2022 9:15 AM ISTUSA: In a new article published in the Journal of American Medical Association, atogepant was shown to be effective and well-tolerated for the...
FDA Approves atogepant for Preventive Treatment of Migraine Hina Zahid30 Sept 2021 9:45 PM ISTNORTH CHICAGO, Ill. - The U.S. Food and Drug Administration has approved atogepant for the preventive treatment of episodic migraine in...
Oral atogepant effective in reducing migraine and headache days: NEJM Medha Baranwal20 Aug 2021 9:00 AM ISTUSA: Once-daily oral atogepant is effective in reducing the number of headache days and migraine days over a period of 12 weeks, show results from a...
